Posted on 04/16/2020 7:59:21 AM PDT by SeekAndFind
As the COVID-19 pandemic continues to spread across the world, killing thousands and bringing economies to their knees, doctors, scientists and governments are on the lookout for safe and effective treatments to help those who are sick. And yet a large issue with COVID-19 is that there is, as yet, no cure.
Though there are treatments that can alleviate the symptoms—such as difficulty breathing—they do not address the underlying cause: the virus. The idea is that treating the symptoms will help prolong a patient's life and buy time for their own immune systems to kick in and remove the infection.
While research into related coronaviruses over the last few decades has brought some promising looking drugs, only large clinical trials on patients with COVID-19 will be able to reveal precisely whether these interventions are safe and effective. Unfortunately, these kinds of large trials take time to carry out, but they are ongoing.
The World Heath Organization (WHO) announced it has helped to launch four "mega trials" against COVID-19 and there are countless more smaller ones coordinated in countries worldwide.
The WHO-backed trials are focusing on drugs that are thought to directly block SARS-CoV-2—the virus strain that causes coronavirus COVID-19—from replicating inside our lungs. Below are some of the main drugs these trials are looking at.
Remdesivir
This is an intravenous antiviral drug that was developed to block infection with related coronaviruses and even Ebola, and is one of the drugs the WHO is helping to investigate.
Remdisivir has already been shown to work against SARS-CoV-2 in cells in a dish in a lab as well as in mice infected with the virus. Remdesivir specifically targets key viral proteins involved in making new copies of the virus and prevents them from working.
Remdesivir has already been used in some COVID-19 patients in the US and appears safe, but large trials are needed to really know if this is the case.
Lopinavir/ritonavir
This is a drug combination used against viruses like HIV. It works in a similar way to remdesivir by blocking key viral proteins called "proteases".
Lopinavir/ritonavir has also been shown to be effective against SARS-CoV-2 in lab cells as well as in mice and is being tested alongside an antiviral drug called interferon beta. This is currently used to treat Multiple sclerosis and can enhance the natural defences of the body's cells against COVID-19.
Chloroquine and hydroxychloroquine
Both of these drugs are currently used to treat malaria and the autoimmune disease lupus. Chloroquine has been tested against lots of different infections because in the lab it can block viruses—including SARS-CoV-2—from getting inside cells placed in a dish and so prevent infection.
Outside the lab, chloroquine has not been demonstrated to have a profound effect at preventing disease and there is limited evidence so far that it can work for COVID-19, despite receiving a lot of hype from President Donald Trump. But again, large trials are needed and the WHO is supporting these.
Caution should be observed with chloroquine as it can have significant side effects in certain people and may even block the immune response—the desired result in lupus treatment.
Two other options
The above potential treatments all work by blocking some key element of the virus infection machinery using small molecules. Two other kinds of treatments are also being explored in trials that work in a different way.
The first is passive immunisation which is the transfer—or transfusion—of potential protective antibodies from someone who has been infected and recovered from COVID-19 to someone who is at high-risk or is suffering from a SARS-CoV-2 infection.
This so-called "convalescent sera" (which is a purified blood product from someone who has recovered from COVID-19) can block SARS-CoV-2 in cells in a dish in the lab and has the potential to help develop treatments. Passive immunisation for COVID-19 is being tested in trials across the world and so far results seem to suggest it is safe to use.
Another kind of possible treatment works by blocking parts of our own immune system that are likely overreacting to SARS-CoV-2 infection and contributing to the damage in our lungs.
In the limited studies that have been conducted on COVID-19, it seems that in some severe cases our immune response goes into overdrive without being able to clear the infection and this can increase the severity of the disease. When this happens, high levels of inflammation is found in the lungs.
Potential treatments that look at blocking the immune components linked to this severity have begun. That said, extreme caution must be taken when manipulating the immune response during an infection as in the absence of other therapies we rely on our immune response to limit the virus replicating.
So although specific treatments for COVID-19 are not yet available, drugs are being tested and clinical trials and starting to yield results. This, combined with the further knowledge that scientists are gaining about SARS-CoV-2 will help massively until a vaccine becomes available.
Nice summary. It is amazing to me “doctors” on TV keep calling it a respiratory virus when it attacks many organs by apparently cutting off oxygen in the blood. ACE inhibitors not good when this thing comes calling.
Breathing issues seems to be a pronounced symptom/affect but heart can be just as badly affected. When lungs have issues you get serious shortness of breath and rush to the hospital. When heart has issues...
Hydroxychloroquine ... plus ZINC ... + Azithromycin or doxycycline Treat early and aggressively.
Chinese fu likes ACE2 receptors. Lots of those in organs like kidneys, heart, and testicles. Treat aggressively and early, to reduce the viral load so immune system can handle and eradicate. Hydroxychloroquine also reduces inflammation, as the reason it is used RA and Lupus, so ...
After much reading this is what I have been sending out to friends and medical activists:
“A Dr. VladimirZelenko in NY is treating patients before they go to hospital with:
Hydroxychloroquine 200mg. twice a day for 5 days,
Azithromycin 500 mg. once a day for 5 days, and
Zinc sulfate 220 mg. once a day for 5 days.
Costs $12, and of 900 patients, only one, who did not follow protocol, has died. No wonder Big Pharma doesn’t want this news to get out. They might have to stop paying their top brass $20million salaries.
I recommend that to build up body stores and strengthen immunity that people take the following:
500mg or 1,000mg. Vitamin C morning and evening;
Vitamin D 5000 IU unless you get out in the sun a lot and DON’T have the darker skin of Latinos and Negros;
a low dose one-a-day type multivitamin/multimineral tablet morning and evening;
2 or 3 calcium/magnesium/zinc tablets a day;
other supplements you normally take.
Ask your doctor about this advice if you are under treatment. It is likely that the people who get really sick are in a state of sub-clinical deficiency before they meet the virus, so the idea is to have well stocked body stores in place.”
Three weeks ago, my son, currently in Special Forces, told me that WHO was calling Google and Facebook and having You-TUbe videos about Vitamin C treatment in China removed. The late Linus Pauling’s Institute has no doubt been pressured to downgrade his earlier recommendations to use high dose Vitamin C for serious illness. See Cathcart’s long, detailed treatment protocol which should be useful for Covid-19. His 9,000 treated cases are one heck of a lot of anecdotes!: http://www.doctoryourself.com/titration.html
p
Well stated,
Thanks for compiling this...
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.